Cyclosporine before PCI in Patients with Acute Myocardial Infarction | Zendy

Thien-Tri Cung | Zendy; Olivier Morel | Zendy; Guillaume Cayla | Zendy; Gilles Rioufol | Zendy; David GarcíaDorado | Zendy; Denis Angoulvant | Zendy; Eric BonnefoyCudraz | Zendy; Patrice Guérin | Zendy; Meyer Elbaz | Zendy; Nicolas Delarche | Zendy; Pierre Coste | Zendy; Gérald Vanzetto | Zendy; M Metge | Zendy; JeanFrançois Aupetit | Zendy; Bernard Jouve | Zendy; Pascal Motreff | Zendy; Christophe Tron | Zendy; Jean-Noël Labèque | Zendy; Philippe Gabríel Steg | Zendy; Yves Cottin | Zendy; Grégoire Rangé | Zendy; J. Clerc | Zendy; Marc J. Claeys | Zendy; Patrick Coussement | Zendy; Fabrice Prunier | Zendy; Frédéric Moulin | Zendy; Olivier Roth | Zendy; Loïc Belle | Zendy; Philippe Dúbois | Zendy; Paul Barragan | Zendy; Martine Gilard | Zendy; Christophe Piot | Zendy; Patrice Colin | Zendy; F. De Poli | Zendy; MarieClaude Morice | Zendy; Omar Ider | Zendy; JeanLuc DuboisRandé | Zendy; Thierry Unterseeh | Zendy; Hervé Breton | Zendy; T Béard | Zendy; Didier Blanchard | Zendy; Gilles Grollier | Zendy; V. Malquarti | Zendy; Patrick Staat | Zendy; Arnaud Sudre | Zendy; Eskil Elmér | Zendy; Magnus J. Hansson | Zendy; Cyrille Bergerot | Zendy; Inesse Boussaha | Zendy; Claire Jossan | Zendy; Geneviève Dérumeaux | Zendy; Nathan Mewton | Zendy; Michel Ovize | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cyclosporine before PCI in Patients with Acute Myocardial Infarction

Author(s) -

Thien-Tri Cung,

Olivier Morel,

Guillaume Cayla,

Gilles Rioufol,

David GarcíaDorado,

Denis Angoulvant,

Eric BonnefoyCudraz,

Patrice Guérin,

Meyer Elbaz,

Nicolas Delarche,

Pierre Coste,

Gérald Vanzetto,

M Metge,

JeanFrançois Aupetit,

Bernard Jouve,

Pascal Motreff,

Christophe Tron,

Jean-Noël Labèque,

Philippe Gabríel Steg,

Yves Cottin,

Grégoire Rangé,

J. Clerc,

Marc J. Claeys,

Patrick Coussement,

Fabrice Prunier,

Frédéric Moulin,

Olivier Roth,

Loïc Belle,

Philippe Dúbois,

Paul Barragan,

Martine Gilard,

Christophe Piot,

Patrice Colin,

F. De Poli,

MarieClaude Morice,

Omar Ider,

JeanLuc DuboisRandé,

Thierry Unterseeh,

Hervé Breton,

T Béard,

Didier Blanchard,

Gilles Grollier,

V. Malquarti,

Patrick Staat,

Arnaud Sudre,

Eskil Elmér,

Magnus J. Hansson,

Cyrille Bergerot,

Inesse Boussaha,

Claire Jossan,

Geneviève Dérumeaux,

Nathan Mewton,

Michel Ovize

Publication year - 2015

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1505489

Subject(s) - medicine , myocardial infarction , percutaneous coronary intervention , cardiology , conventional pci , angina , culprit , placebo , ventricular remodeling , heart failure , adverse effect , stroke (engine) , alternative medicine , pathology , engineering , mechanical engineering

Experimental and clinical evidence suggests that cyclosporine may attenuate reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine would improve clinical outcomes and prevent adverse left ventricular remodeling.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research